Hubei Guangji Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 180.16 million compared to CNY 115.29 million a year ago. Revenue was CNY 180.16 million compared to CNY 115.29 million a year ago.

Net loss was CNY 50.51 million compared to CNY 44.04 million a year ago. Basic loss per share from continuing operations was CNY 0.1427 compared to CNY 0.1244 a year ago. Diluted loss per share from continuing operations was CNY 0.1427 compared to CNY 0.1244 a year ago.